ARTICLE | Clinical News
M40403: Phase II started
May 3, 2004 7:00 AM UTC
Metaphore will begin this month a double-blind, placebo-controlled, U.S. Phase II trial in 350 patients undergoing bunionectomy. The trial will compare 3 doses of M40403 in combination with 1 dose of ...